0,820  0,009  Caspase 9 stimulant
0,802  0,004  5 Hydroxytryptamine release stimulant
0,671  0,005  CYP2C19 inhibitor
0,663  0,005  CYP2D6 inhibitor
0,644  0,025  Antineoplastic (lung cancer)
0,589  0,017  Antidepressant
0,575  0,004  Alpha 2 adrenoreceptor antagonist
0,582  0,020  Mood disorders treatment
0,562  0,010  Cardiodepressant
0,527  0,017  Caspase 3 stimulant
0,516  0,012  Antineoplastic (glioblastoma multiforme)
0,506  0,010  Sedative
0,528  0,032  Antineoplastic (colorectal cancer)
0,525  0,030  Antineoplastic (colon cancer)
0,499  0,006  Alpha adrenoreceptor antagonist
0,499  0,007  5 Hydroxytryptamine antagonist
0,488  0,004  Neurotrophic factor enhancer
0,508  0,026  Histamine release inhibitor
0,499  0,019  Antineoplastic (glioma)
0,495  0,018  Antineoplastic (non-small cell lung cancer)
0,482  0,017  CYP1A2 inhibitor
0,499  0,054  Antineoplastic (breast cancer)
0,458  0,014  Sigma receptor agonist
0,457  0,026  Antineoplastic (brain cancer)
0,446  0,020  CYP3A4 inhibitor
0,429  0,004  Alpha 2a adrenoreceptor antagonist
0,454  0,030  Spasmolytic
0,498  0,075  Apoptosis agonist
0,452  0,034  Antineoplastic (ovarian cancer)
0,424  0,009  5 Hydroxytryptamine 2 antagonist
0,454  0,040  Prostate cancer treatment
0,420  0,009  Male reproductive disfunction treatment
0,421  0,012  Muscle relaxant
0,437  0,038  Respiratory analeptic
0,427  0,035  Antineoplastic (melanoma)
0,418  0,029  Antineoplastic (multiple myeloma)
0,396  0,012  Antineoplastic (squamous cell carcinoma)
0,417  0,035  Antiischemic
0,395  0,017  Cyclic AMP phosphodiesterase inhibitor
0,414  0,040  Hepatic disorders treatment
0,401  0,032  NOS2 expression inhibitor
0,423  0,057  Antileukemic
0,374  0,008  5 Hydroxytryptamine 2A antagonist
0,364  0,005  Alpha 2b adrenoreceptor antagonist
0,368  0,012  Skeletal muscle relaxant
0,358  0,014  Tubulin antagonist
0,430  0,089  Antineoplastic (solid tumors)
0,371  0,030  Antineoplastic (renal cancer)
0,350  0,012  Antiischemic, cerebral
0,373  0,045  Vasodilator, coronary
0,357  0,031  Antimitotic
0,343  0,027  Abortion inducer
0,318  0,005  Dopamine D1 antagonist
0,319  0,016  Topoisomerase II inhibitor
0,373  0,070  Transcription factor NF kappa B inhibitor
0,309  0,013  Antiadrenergic
0,310  0,017  Cholinergic
0,306  0,013  Adrenaline antagonist
0,298  0,011  Topoisomerase I inhibitor
0,308  0,027  Hepatoprotectant
0,301  0,022  Antineoplastic (carcinoma)
0,291  0,014  Acetylcholinesterase inhibitor
0,285  0,009  5 Hydroxytryptamine agonist
0,324  0,049  DNA damaging
0,289  0,017  Erectile dysfunction treatment
0,278  0,008  Phobic disorders treatment
0,297  0,029  P-glycoprotein inhibitor
0,284  0,016  Bipolar disorder treatment
0,321  0,055  Antineoplastic (small cell lung cancer)
0,348  0,082  CYP2C9 inhibitor
0,323  0,060  Antineoplastic (pancreatic cancer)
0,325  0,067  12-Lipoxygenase inhibitor
0,264  0,014  Dopamine antagonist
0,353  0,103  Antiparkinsonian
0,259  0,009  Breast cancer-resistant protein inhibitor
0,303  0,066  CYP1A2 substrate
0,295  0,059  Antineoplastic (cervical cancer)
0,247  0,013  Dopamine D2 antagonist
0,287  0,054  Antineoplastic (lymphoma)
0,275  0,043  Antineoplastic enhancer
0,276  0,044  Antiparkinsonian, rigidity relieving
0,256  0,026  Lipid peroxidase inhibitor
0,247  0,017  Uterine stimulant
0,301  0,074  Analeptic
0,239  0,016  Alpha 1 adrenoreceptor antagonist
0,296  0,078  Anxiolytic
0,271  0,054  Antineoplastic (sarcoma)
0,236  0,021  CDC-like kinase 1 inhibitor
0,221  0,009  Antineoplastic alkaloid
0,225  0,013  Alpha 2c adrenoreceptor antagonist
0,268  0,056  5 Hydroxytryptamine 1E antagonist
0,214  0,005  Alpha tubulin antagonist
0,230  0,021  5 Hydroxytryptamine 2B antagonist
0,255  0,051  Chemopreventive
0,300  0,097  Vasodilator, peripheral
0,231  0,031  LDLR expression enhancer
0,263  0,067  Antineoplastic (bladder cancer)
0,263  0,067  Myocardial infarction treatment
0,207  0,014  5 Hydroxytryptamine 1A antagonist
0,198  0,007  CDC-like kinase 3 inhibitor
0,215  0,026  Antifungal enhancer
0,218  0,030  Heat shock protein 90 antagonist
0,221  0,034  Acetylcholine M1 receptor antagonist
0,197  0,011  Dopamine D3 antagonist
0,205  0,020  Butyrylcholinesterase inhibitor
0,266  0,087  Hypoxia-inducible factor 1 alpha inhibitor
0,191  0,014  Calcium antagonist
0,180  0,004  Heat shock protein 90 beta antagonist
0,186  0,010  Alpha adrenoreceptor agonist
0,181  0,009  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,205  0,033  Genotoxic
0,197  0,027  DNA intercalator
0,178  0,009  Beta tubulin antagonist
0,227  0,058  Nitric oxide antagonist
0,241  0,073  Antineoplastic (lymphocytic leukemia)
0,250  0,083  Antioxidant
0,205  0,039  Melanin inhibitor
0,186  0,021  Adenylate cyclase stimulant
0,264  0,099  CYP2D6 substrate
0,210  0,048  5 Hydroxytryptamine 3E antagonist
0,221  0,061  Platelet adhesion inhibitor
0,162  0,005  5 Hydroxytryptamine 2C agonist
0,182  0,025  MAP3K9 inhibitor
0,243  0,088  5 Hydroxytryptamine uptake stimulant
0,218  0,069  Clk dual-specificity kinase inhibitor
0,168  0,020  5 Hydroxytryptamine 1 antagonist
0,219  0,072  Pyruvate kinase inhibitor
0,273  0,126  Stroke treatment
0,150  0,005  5 Hydroxytryptamine 2 agonist
0,216  0,072  Psychostimulant
0,284  0,141  TNF expression inhibitor
0,194  0,055  Thrombolytic
0,158  0,022  Topoisomerase II alpha inhibitor
0,142  0,007  Alpha 2 adrenoreceptor agonist
0,144  0,011  Acetylcholine M4 receptor antagonist
0,215  0,084  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,132  0,003  Ryanodine receptor antagonist
0,274  0,147  15-Lipoxygenase inhibitor
0,140  0,013  Phosphodiesterase V inhibitor
0,139  0,013  Phosphodiesterase 11A inhibitor
0,139  0,013  Phosphodiesterase XI inhibitor
0,183  0,057  Antineoplastic (bone cancer)
0,175  0,049  MAO inhibitor
0,162  0,038  MAO A inhibitor
0,250  0,132  CYP3A4 substrate
0,203  0,085  VCAM1 expression inhibitor
0,190  0,072  VEGF expression inhibitor
0,131  0,015  Phosphodiesterase 5A inhibitor
0,140  0,025  Alpha 1a adrenoreceptor antagonist
0,131  0,019  5 Hydroxytryptamine uptake inhibitor
0,176  0,065  UGT1A3 substrate
0,218  0,107  UGT1A9 substrate
0,217  0,107  Tyrosine 3 hydroxylase inhibitor
0,185  0,076  CDC-like kinase 4 inhibitor
0,140  0,032  Sphingosine 1-phosphate receptor 2 agonist
0,203  0,097  Dyrk kinase inhibitor
0,155  0,051  NADPH oxidase inhibitor
0,112  0,011  5 Hydroxytryptamine 2A agonist
0,204  0,106  Tumour necrosis factor alpha release inhibitor
0,141  0,043  Antiviral (Papilloma)
0,148  0,051  Acetylcholine antagonist
0,185  0,088  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,149  0,053  Cholinergic antagonist
0,102  0,007  5 Hydroxytryptamine 7 agonist
0,119  0,025  Inducible nitric-oxide synthase inhibitor
0,129  0,036  DOPA decarboxylase inhibitor
0,101  0,009  Potassium channel (Ca-activated) blocker
0,165  0,073  Heat shock protein 90 alpha antagonist
0,145  0,053  Cyclooxygenase 3 inhibitor
0,179  0,088  Focal adhesion kinase 2 inhibitor
0,091  0,003  Phenylethanolamine N methyltransferase inhibitor
0,137  0,053  Acetylcholine muscarinic antagonist
0,195  0,112  Antineoplastic (liver cancer)
0,127  0,045  Activin receptor-like kinase 4 inhibitor
0,202  0,120  Antipsychotic
0,134  0,054  Papain-like protease (SARS coronavirus) inhibitor
0,108  0,029  ATPase (Vacuolar H+) inhibitor
0,134  0,055  Antineoplastic (uterine cancer)
0,146  0,069  MAP kinase kinase 4 inhibitor
0,145  0,069  Attention deficit/hyperactivity disorder treatment
0,189  0,114  Vasodilator
0,153  0,078  Carcinogenic, group 1
0,132  0,058  Antiviral (Hepatitis B)
0,096  0,023  Female sexual dysfunction treatment
0,157  0,086  Liver fibrosis treatment
0,182  0,112  Antiprotozoal (Leishmania)
0,169  0,101  CYP2B6 inhibitor
0,145  0,080  GABA C receptor rho-2 antagonist
0,192  0,127  Superoxide dismutase inhibitor
0,116  0,052  MAO B inhibitor
0,108  0,048  Nitric-oxide synthase inhibitor
0,193  0,134  DNA synthesis inhibitor
0,158  0,100  Cytotoxic
0,066  0,009  Dopamine D5 agonist
0,119  0,062  Microtubule formation inhibitor
0,183  0,127  RNA-directed DNA polymerase inhibitor
0,223  0,168  Antiprotozoal (Plasmodium)
0,135  0,081  UGT2B15 substrate
0,101  0,048  SULT1E1 substrate
0,137  0,087  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,150  0,101  Tumour necrosis factor antagonist
0,097  0,047  5 Hydroxytryptamine 2C antagonist
0,075  0,027  5 Hydroxytryptamine 5A antagonist
0,156  0,108  Non-steroidal antiinflammatory agent
0,209  0,162  ICAM1 expression inhibitor
0,171  0,126  Antihypercholesterolemic
0,059  0,018  Factor III inhibitor
0,051  0,010  Endothelin receptor antagonist
0,067  0,025  Melanin-concentrating hormone receptor 1 antagonist
0,127  0,088  Activin receptor-like kinase 2 inhibitor
0,045  0,006  Endothelin B receptor antagonist
0,070  0,031  Acetylcholine M5 receptor antagonist
0,067  0,028  5 Hydroxytryptamine 5 antagonist
0,122  0,084  Toll-Like receptor 9 antagonist
0,073  0,035  Acetylcholine M2 receptor antagonist
0,067  0,030  Alpha 1 adrenoreceptor agonist
0,080  0,044  Glutamate decarboxylase inhibitor
0,076  0,040  Premenstrual syndrome treatment
0,108  0,073  Interleukin 1b antagonist
0,096  0,061  Phosphodiesterase 6D inhibitor
0,069  0,035  Adrenaline uptake inhibitor
0,159  0,126  Pneumotoxic
0,081  0,049  Nicotinic alpha4beta2 receptor antagonist
0,062  0,031  Postmenopausal disorders treatment
0,060  0,029  Myc inhibitor
0,115  0,083  DNA repair enzyme inhibitor
0,129  0,098  Antiviral (Herpes)
0,137  0,108  Cystic fibrosis treatment
0,161  0,132  Free radical scavenger
0,149  0,121  UGT1A1 substrate
0,096  0,068  GABA C receptor rho-1 antagonist
0,055  0,027  Topoisomerase II beta inhibitor
0,077  0,049  GABA B receptor agonist
0,141  0,115  Amyloid beta aggregation inhibitor
0,142  0,117  UGT2B10 substrate
0,082  0,057  T cell inhibitor
0,076  0,052  Antitreponemal
0,043  0,020  5 Hydroxytryptamine 2B agonist
0,049  0,026  Dopamine D5 antagonist
0,112  0,091  Antismoking
0,074  0,053  Phosphodiesterase VI inhibitor
0,135  0,114  Myocardial ischemia treatment
0,061  0,040  Acetylcholine M3 receptor antagonist
0,102  0,082  Antitussive
0,030  0,010  Endothelin A receptor antagonist
0,039  0,022  Integrin alpha2 antagonist
0,065  0,048  Dopamine agonist
0,029  0,013  Dopamine autoreceptor agonist
0,087  0,072  Obsessive-compulsive disorder treatment
0,056  0,041  5 Hydroxytryptamine 6 antagonist
0,066  0,051  Glutamate (mGluR7) antagonist
0,174  0,159  Proliferative diseases treatment
0,024  0,010  Imidazoline I1 receptor antagonist
0,177  0,164  Chemoprotective
0,169  0,156  Antihypotensive
0,113  0,102  Antiparkinsonian, tremor relieving
0,088  0,077  Dementia treatment
0,112  0,101  Antihemorrhagic
0,051  0,041  Nicotinic alpha3beta2 receptor antagonist
0,101  0,091  Antiseptic
0,038  0,028  Vesicle monoamine transporter inhibitor
0,085  0,076  Vascular dementia treatment
0,167  0,158  Radioprotector
0,065  0,056  Histidine decarboxylase inhibitor
0,057  0,048  5 Hydroxytryptamine 7 antagonist
0,190  0,183  Antihypertensive
0,126  0,119  Pulmonary hypertension treatment
0,022  0,017  Dopamine D1 agonist
0,090  0,084  Estrogen receptor beta antagonist
0,155  0,150  Cytostatic
0,041  0,037  5 Hydroxytryptamine 1A agonist
0,031  0,027  Melatonin 1 agonist
0,198  0,196  CYP2C9 substrate
0,134  0,132  3C-like protease (Human coronavirus) inhibitor
0,069  0,068  Keratolytic

